ACTRN12621000150842招募中未知
The impact of body composition on the pharmacokinetics and pharmacodynamics of propofol infusions in neonates infants and children
niversity of Auckland0 个研究点目标入组 50 人开始时间: 2021年2月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- Years 至 15 Years（—）
- 性别
- All
入选标准
- •Participants will include 50 neonates infants and children aged 0-15 years undergoing surgical procedures at Starship Children’s Hospital. This study will include both obese and non-obese children. Obesity will be determined based on a BMI > 95% for age and sex, determined by the Children’s BMI calculator and assigned to one of 3 categories as defined as the % above the 95th centile, as follows:
- •Obesity Grade I: > 95%-120% of 95th percentile (adult BMI >30 -35 equivalent)
- •Obesity Grade II: 120-140% of 95th percentile (adult BMI 35- 40 equivalent)
- •Obesity Grade III: > 140% of 95th percentile (adult BMI > 40 equivalent)
排除标准
- •Children undergoing cardiac or liver transplant surgery will not be included.
研究者
相似试验
招募中
不适用
The effects of body composition on pharmacokinetics of propofolKCT0004196Chonbuk National University Hospital100
招募中
不适用
The effect of body composition on infliximab (remicade/inflectra) on inflamamtory bowel disease (Crohn's disease, Colitis Ulcerosa)NL-OMON28109Zuyderland Medisch CentrumAfdeling MDL en Klinische farmacologie33
暂停
不适用
The effect of body composition on the farmacokinetiek IFX in patients with inflammtoy bowel disease;Crohn's diseaseInflammatory Bowel DiseaseNL-OMON46317Zuyderland Medisch Centrum33
撤回
1 期
Doxorubicin Pharmacokinetic (PK) StudyCancerNCT00124956Boston Children's Hospital
招募中
Unknown
Body composition analysis by InBodyS10 and perioperative management of cardiovascular surgerycardiovascular diseaseJPRN-UMIN000049927St Marianna University School of Medicine200